Abstract: Objective To investigate the relations between neuroapoptosis and the onset and development of Alzheimer's disease (AD), especially the role of NF-κB in the regulation of neuroapoptosis. Methods expressions in the CA3 region of the hippocampus in APPswe Tg2576 transgenic mice were studied from postnatal day 0-180, using Nissl staining, immunohistochemistry and RT-PCR methods. Results Both neuronal apoptosis and NF-κB activity decreased gradually with the increase of age in wild type and Tg2576 mice. However, the number of caspase-3-positive or NF-κB-positive pyramidal cells in Tg2576 mice was greater than that in age-matched wild type mice, with significant differences after postnatal day 14 (P < 0.01 or P < 0.05). Linear regression analyses of caspase-3 and NF-κB expression demonstrated a correlation between neuroapoptosis and activity of NF-κB. Conclusion The process of neuroapoptosis is consistent with the onset and development of AD. Furthermore, the observed correlation between neuroapoptosis and NF-κB activity suggests a role of NF-κB in hippocampal neuroapoptosis.
Introduction
Alzheimer's disease (AD) is a devastating disease affecting the health of many people aged over 65 years. Symptoms of AD include memory loss, language deterioration, poor judgment, confusion and mood swings. The neuropathology of AD is characterized by amyloid plaques, neurofibrillary tangles and degeneration of neurons and synapses [1] .
In the present study, neuroapoptosis was investigated in APPswe Tg2576 transgenic mice at different developmental stages using caspase-3 immunocytochemistry in an effort to further understand the development of neuroapoptosis in AD.
In addition, activation of NF-κB in the hippocampus was analyzed. Understanding the role of NF-κB in neuroapoptosis will be beneficial to development of novel strategies for pharmacological intervention in many neurodegenerative diseases.
Materials and methods

Animals
APPswe Tg2576 transgenic mice were used in the present study. Hemizygous males (transgenic mice, TM) encoding the Swedish FAD double mutation, HuAPP695SWE
under the control of a hamster prion protein promoter [2] , were crossed with wild type (WT) female mice on a hybrid C57BL/ 6-SJL background. All the mice were born and bred in the animal housing facilities at the Institute of Neurobiology at Henan University, under a 12-h light/dark cycle. Tail DNA was extracted from P10 animals (P = postnatal days; P0 = the first 24 h after birth) and genotyping was performed by PCR to detect hAPPswe positive animals using the following primers: 5' GTG GAT AAC CCC TCC CCC AGC CTA GAC CA 3' and 5' CTG ACC ACT CGA CCA GGT TCT GGG T 3'. Offspring genotypes were identified as WT (-/-, normal mice lacking a PCR band) and heterozygote (+/-, with a 466 bp PCR band). For the behaviour, Tg2576 mice appeared slower in reaction than WT mice did after postnatal 3 months. In addition, Tg2576 mice usually could not live for longer than 8 months. The survival rate at the age of 6 months for Tg2576 mice was 82% vs 95% for WT. At the age of one year, the survival rate of Tg2576 mice was less than 10% compared to 91% of WT mice. Behaviour and survival rates in Tg2576 mice were consistent with AD onset and progression. In order to find the progressive course of AD, several age points were selected to investigate neuroapoptosis and brain pa- 
Immunofluorescent double labeling
In order to determine whether cells were positive for both caspase-3 and NF-κB, immunofluorescent double labeling was employed. Sections were prepared as described above. After being rinsed for several times, sections were incubated with both polyclonal goat anti-caspase-3 (1:1 000, Santa Cruz) and polyclonal rabbit anti-p50 (1:200, Santa Cruz) antibodies overnight at 4 ºC.
After that, the corresponding secondary antibodies goat antirabbit IgG (1:300, Invitrogen) and donkey anti-goat IgG (1: 600, Invitrogen) were added and sections were incubated at room temperature for 3 h. After being washed for 3 times, sections were coverslipped with mounting medium and imaged with an epifluorescent microscope (BX61, Olympus).
High quality sections were photographed with a confocal microscope (FV10, Olympus) using separate scans for the 568 and 488 nm laser lines.
RT-PCR
Since RT-PCR is a sensitive method for detection of mRNA expression, caspase-3 mRNA expression was tested using this method. Hippocampal RNA was extracted using TRIzol reagent [3] . RNA was reverse transcribed into cDNA using a Reverse Transcription System Kit according complex from IκB in the cytoplasm and transference to the nucleus [4] . Therefore, immunoreactive cells demonstrating brown staining in either nuclei only or in nuclei and cytoplasm were regarded as activated NF-κB-positive cells. Cells with or without brown staining in the cytoplasm were recognized as negative cells (Fig. 1A , B and C). 
Parameters and measurements
Data analysis
The developmental trend of neuronal loss and neuroapoptosis was compared between Tg2576 and WT mice. Data were presented as mean±SD and analyzed with t tests at each developmental stage. A correlative test between the density of caspase-3-positive neurons and density of NF-κB-positive neurons was carried out using linear regression analysis. P < 0.05 was considered as statistically significant.
Results
General pathology and neuronal loss in Tg2576 mice
The hippocampus is highly laminated, in terms of its cell and (Table 1 ).
This phenomenon of neuronal reduction resulted in a thinner pyramidal layer with less cells (Fig. 2A , B and C). In contrast, at P0, the pyramidal layer was thick, and pyramidal cells were densely packed. The pyramidal cells appeared young, with little cytoplasm and resembled lymphocytes.
However, with the increase of age, pyramidal cells grew larger and developed a mature structure --triangular in shape with abundant cytoplasm, large nuclei and clear nucleoli. The number of pyramidal cells was stable after P30 ( Fig. 2A, B and C). Although the developmental trend was similar in both groups, differences did exist between Tg2576 and WT mice.
There were obvious neuronal loss and neuroapoptosis in Tg2576 mice. The number of neurons in Tg2576 and WT mice throughout the developmental time course was shown in Table 1 . In the Tg2576 mice, the density of pyramidal cells was smaller than that in WT mice after P7. In addition, there was obvious neuroapoptosis at P180, and irregular polarity of apoptotic cells, and the cells exhibited concentrated cytoplasm with visible apoptotic bodies in the pyramidal layer (Fig. 2D , E and F).
Caspase-3-dependent neuroapoptosis
Activated caspase-3-positive pyramidal cells in the
CA3 area Caspase-3 is a pro-apoptotic cytoplasmic enzyme.
Here, activated caspase-3 was used as a marker to label apoptotic cells. Apoptotic neurons were positive for DAB staining which could reflect the level of activated caspase-3 in the cytoplasm, and were stained with hematoxylin marking the nucleus, while normal neurons were stained only with hematoxylin ( Fig. 1B, C) . During early development of the central nervous system (CNS), neuroapoptosis is often found in the proliferative zone and in young neurons, since numer- ous non-functional cells are waiting to be eliminated through apoptosis. As development proceeds, neuroapoptosis decreases as mature synapses are established among neurons [5] . In the present study, developmental trend of neuroapoptosis in (Fig. 1B, C) . Neuroapoptosis in Tg2576 mice was more severe than that in age-matched WT mice (Fig. 1) . Table 2 showed the density of caspase-3-positive pyramidal cells (cells/mm 2 ) in the CA3 area of WT and Tg2576 mice. Statistically significant differences appeared after P14 (P > 0.05 at P0 and P7, P < 0.05 from P14 -P180), indicating a close correlation between hippocampal neuroapoptosis and AD development.
Caspase-3 mRNA expression in hippocampus
To further confirm the results of immunohistochemistry assay, semiquantitative RT-PCR was carried out to measure expression of caspase-3 mRNA in Tg2576 and WT mice at different ages. β-Actin served as an internal control. To improve the accuracy of PCR results, each sample was measured in duplicate, and the average value was used for further analysis. At least 3 animals were included in each age group. As shown in Fig.   3 , the results were consistent with that of the caspase-3
immunohistochemistry. Expression level of caspase-3 mRNA in Tg2576 mice was higher than that in WT mice after P14.
However, before P14, there was no obvious difference between Tg2576 and WT mice. Table 3 listed the caspase-3/β-actin ratio measured by densitometry at different ages. (Table 4 , Fig. 1D-I ). Although the developmental trends of NF-κB activation in Tg2576 and WT mice were similar, NF-κB activation in Tg2576 mice was statistically greater than that in WT mice after P14 (P > 0.05 before P14, P < 0.05 from P14-P180, t test; Table 4 , Fig. 1D-I ).
NF-κB and caspase-3 activation
NF-κB activation in CA3 pyramidal cells
Correlation between caspase-3 activation and NF-κB activity
In order to examine the correlation between caspase-3 activation and NF-κB activity, linear regression and correlation tests were carried out. Table 2 and Table 4 rons with non-functional synapses are eliminated during the normal development process through neuroapoptosis [6] . On the other hand, neuroapoptosis also plays an important role in clearing away sick cells in neurodegenerative disease [7] .
Investigation in neuroapoptosis during CNS development may shed light on the pathogenesis of AD. The process of neuroapoptosis is highly controlled, in which many genes participate. NF-κB is considered as a candidate for active regulation of neuroapoptosis. Understanding the role of NF-κB in neuroapoptosis may be helpful for develop novel therapies for pharmacological intervention in AD. twisted fibers built up inside the neuron [8] . Neurofibrillary tangle formation in the CA3 region of the hippocampus is an early event of AD pathogenesis [9] . As the disease progresses, more neurofibrillary tangles are formed with substantial neuronal loss in the hippocampus and cortex [10] . In AD, loss of synaptic connections and neurons occurs in the cerebral cortex, hippocampus and certain subcortical regions, which results in gross atrophy of the affected regions [11] . Surprisingly, some neuroregeneration can occur in tandem with chronic neuroapoptosis in an attempt to compensate for neuronal loss. Moreover, biochemical evidence demonstrates a loss of choline acetyltransferase and acetylcholine in the cerebral cortex of patients with AD [12] .
Pathological alterations in
In the current study using a combination of HE staining and Nissl method, hippocampal pathology and neuronal loss were investigated in Tg2576 mice. In general, the number of pyramidal cells in the CA3 region reduced gradually with age, but we observed that neuronal loss was more severe in Tg2576 mice compared with that in age-matched WT mice.
At P180, apoptotic bodies were found among pyramidal cells, suggesting a link between amyloid plaques and neuronal loss in Tg2576 mice. These observations are consistent with the study of Schmitz et al. [13] , in which Tg2576 mice express-ing human mutant amyloid precursor protein APP751
(KM670/671NL and V717I) and human mutant presenilin-1 (PS-1 M146L) were investigated. Their data revealed a substantial age-related neuronal loss in the hippocampal pyramidal cell layer of APP/PS-1 double-transgenic mice. The apoptotic bodies found in the present study suggest the neuroapoptosis to be a main cause for neuronal loss, probably resuting from Aβ toxicity.
Caspase-3-dependent apoptosis in Tg2576 and WT mice
during development It is well accepted that massive neuronal and glial death occurring in AD is caused by apoptosis.
Using immunocytochemistry method, Su et al. [14] have demonstrated substantial neuroapoptosis in the hippocampus and entorhinal cortex of AD brain, consistent with the notion that apoptosis is the primary mechanism leading to neuronal death in AD. There are 2 types of apoptosis: caspase-dependent apoptosis and caspase-independent apoptosis (autophagy). The majority of cell death in neurodegenerative disease occurs through caspase-dependent apoptosis. Multiple extrinsic and intrinsic stimulations lead to cell death through different pathways culminating in proteolytic activation of caspases-3. Activated caspase-3 subsequently cleaves a specific set of protein substrates, such as procaspases themselves, resulting in mediation and amplification of the death signal and eventually cell death [15] . Since caspase-3 activation is the convergence of apoptotic pathways, the presence of active caspase-3 is often used to mark caspase-dependent apoptosis. We have previously used activated caspase-3 to detect neuroapoptosis occurring as a result of prenatal alcohol exposure with satisfactory results [16] .
In the present study, neuroapoptosis in Tg2576 mice was studied at various developmental stages using caspase- Prior to P14, no differences were found between the two groups, but after P14 differences appeared between WT and Tg2576 mice. The symptoms of AD usually appear in middleaged patients and progress over time. Our data are consistent with the correlation between neuroapoptosis and AD development.
Activation of NF-κB-and caspase-3-dependent apoptosis
NF-κB, a nuclear transcription factor, plays an important role in many physiological and pathological processes, including development, synaptic plasticity, immune regulation, inflammatory response, cancer and degenerative disease [17, 18] .
Given the role of NF-κB in inflammation, it is not surprising that NF-κB is found to be chronically active in many inflammatory diseases including inflammatory bowel disease, arthritis, sepsis and asthma. In eukaryotic cells, NF-κB also acts as a regulator for cell proliferation and survival. The role of NF-κB in apoptosis remains controversial. NF-κB has been demonstrated to promote cell proliferation and protect the cell from apoptosis [19] . The anti-apoptosis function of NF-κB most likely occurs through suppression of tumor necrosis factor α (TNF-α) signaling [20] . On the other hand, NF-κB is also suggested to up-regulate apoptosis [21] , and may lead to an increase of caspase-3 activity and neuroapoptosis [22] .
In the present study, the role of NF-κB in neuroapoptosis was investigated. In both Tg2576 and WT mice, the activities of NF-κB and caspase 3 were similar in CA3 pyramidal cells.
The highest NF-κB activity was detected at P0, and gradually decreased with age. However, activation level of NF-κB was significantly higher in Tg2576 mice than that in WT mice after P14. The similarity in patterns of caspase-3 activation and NF-κB activity during development suggested a positive correlation between NF-κB activity and neuroapoptosis. To seek further evidence for a connection between NF-κB and caspase-3 activation, immunofluorescent double labeling was employed. The results demonstrated co-expression of caspase-3 and NF-κB in some cells, lending further credence to the notion of a connection between NF-κB activity and neuroapoptosis. The mechanism by which NF-κB acts to upregulate neuroapoptosis has not been well understood.
Apoptosis-related proteins such as Bcl-2 and caspase-3 are suggested to be involved in the regulation of neuroapoptosis [23] .
Since apoptosis is a common pathological event in AD, prevention of neuroapoptosis offers a novel therapeutic approach for treatment of the disease. Inhibition of NF-κB activity may suppress neuroapoptosis and ultimately slow the progression of AD.
In summary, a reduction in the number of hippocampal neuronal cells occurred during CNS development in WT mice, and a pathological neuronal loss occurred in Tg2576 mice.
Neuroapoptosis in Tg2576 mice was more severe than that in WT mice after P14, which suggests that neuroapoptosis is correlated with AD development. A positive correlation was detected between NF-κB activity and caspase-3 activation, suggesting that NF-κB may lead to up-regulation of neuroapoptosis.
Taken together, the present study suggests that inhibition of NF-κB may potentially provide a therapeutic target for AD treatment.
